Advisory Board

As with Rhenman Healthcare Equity L/S, the Investment Team of Rhenman Global Opportunities L/S work closely with a board of renowned experts and market analysts. For this fund, they provide the managers with in-depth knowledge of the global financial markets. The board members also have an extensive network of experts in many different fields, both in Sweden and abroad.

 

THE BOARD PROVIDES THE INVESTMENT TEAM WITH IN-DEPTH KNOWLEDGE

The portfolio managers and the Board have four formal meetings each year with in-depth discussions on topics chosen by the Investment Team. The Board is chaired by Staffan Knafve. He requests the members’ expertise on topics that are relevant to the fund. In addition to the established quarterly meetings, the individual members of the Board are consulted regularly by the Investment Team.

 

Investment Team

 

  • Ewa Björling

    EWA BJÖRLING

    Ewa is, among other things, board member of SCA and BioGaia, and served as Minister of Trade in the Swedish Government 2007-2014.

  • Jan Risberg

    JAN RISBERG

    Independent Financial Advisor with over 25 years experience in international capital markets, including Aros, SEB Enskilda and Ledstiernan.

  • Henrik Mitelman

    HENRIK MITELMAN

    Market Analyst and Strategist, and, among other things, market columnist at Dagens Industri and former Chief Analyst at SEB.